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Structured Summary 
OBJECTIVES: To evaluate whether screening tests used to identify infectious and neoplastic triggers 
for immune mediated haemolytic anaemia (IMHA), in particular a complete blood count and 
differential (CBC), serum biochemistry profile, urine analysis (including culture), abdominal ultrasound 
and thoracic radiographs, can identify triggers for steroid responsive meningitis-arteritis (SRMA).  
METHODS: Retrospective descriptive review. 
RESULTS: Twenty-one SRMA cases were identified in which all screening tests had been performed. 
All cases had changes in CBC (including neutrophilia, monocytosis, lymphocytosis, eosinopenia or 
anaemia); 19 had changes in biochemistry (including hypoalbuminaemia, hyperglobulinaemia, 
increased ALP activity, hyperphosphataemia, increased total calcium concentration, 
hypercholesterolaemia, hyperkalaemia, increased urea concentration and increased ALT activity); two 
cases had an elevated urine protein to creatinine ratio but none had positive urine culture results; no 
cases had abnormalities on orthogonal radiographs of the thorax; four cases had abnormalities 
identified on abdominal ultrasound, which following cytological examination suggested inflammation in 
the absence of pathological organisms.  
CLINICAL SIGNIFICANCE: Screening tests used to identify infectious and neoplastic triggers in IMHA 
did not isolate triggers for SRMA in the population of dogs under investigation.  
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Introduction 
Dogs with steroid responsive meningitis-arteritis (SRMA) have inflammatory lesions of the 
leptomeninges and associated arteries that are responsive to corticosteroids (De Lahunta and Glass, 
2009). SRMA may occur in any breed and has been reported in dogs from 3 months (Harcourt, 1978) 
to 9 years (Cizinauskas et al., 2000), but onset is typically between 6 and 18 months of age (Tipold 
and Schatzberg, 2010). Cases of SRMA have a waxing-waning disease characterized by episodes of 
cervical hyperaesthesia, depression and pyrexia (De Lahunta and Glass, 2009). There is no definitive 
ante-mortem diagnostic test for SRMA and diagnosis is based on clinical signs, laboratory findings 
and exclusion of other diseases (Lowrie et al., 2009).  
 
The aetiopathogenesis of SRMA is unknown (Tipold and Schatzberg, 2010), but a T helper 2 cell (Th-
2) mediated immune response is suspected (Schwartz et al., 2011). Given the presence of activated T 
cells an antigenic stimulus is believed to trigger SRMA, but no infectious agents have been identified 
to date (Harcourt, 1978; Meric et al., 1985, Scott-Moncrieff et al., 1992). Other immune mediated 
diseases, such as immune mediated haemolytic anaemia (IMHA), have activated T cells as part of 
their pathogenesis (Day and Mackin, 2008). In particular a Th-2 mediated immune response is 
suspected in IMHA (Whitley and Day, 2011).  Twenty-five to forty percent of IMHA cases have their 
antigenic triggers identified and infections, neoplasms, drugs and controversially vaccinations have all 
been implicated (Duval and Giger, 1996; Mitchel and Kruth, 2011). There is no consensus on how 
best to identify these triggers in IMHA but current recommendations are to use screening tests, 
including  a complete blood count (CBC) with differential, serum biochemistry profile, urine analysis 
(including culture), abdominal ultrasound and radiographs of the thorax (Miller, 2008).  
 
Given the similarity in the immune mediated response between SRMA and IMHA it is reasonable to 
use the screening tests for IMHA to identify infectious or neoplastic triggers for SRMA. The aim of this 
study was to perform a retrospective review of SRMA cases and their screening test results to identify 
if any infectious or neoplastic triggers could be identified. 
 
Materials and Methods 
SRMA cases were identified by retrospectively searching clinical records of cases presenting to 
Langford veterinary services, University of Bristol between 2002 and 2011. Cases were included if 
they had a full history, record of a general physical and neurological examination; clinical signs of 
neck pain, depression and pyrexia; a cerebrospinal fluid (CSF) sample which documented 
neutrophilic pleocytosis with an absence of pathological organisms on routine cytology;  CBC with 
differential, serum biochemistry profile and orthogonal cervical radiographs that excluded other 
causes for neck pain; cystocentesis urine analysis (including culture), complete abdominal ultrasound 
and orthogonal inflated thoracic radiographs. Cases were excluded if they had neurological deficits in 
addition to neck pain and depression or were over 18 months of age at presentation.  
 
Neck pain was defined as displaying a behavioural change (vocalisation or biting), or a decreased 
range of movement, when the cervical spine was manipulated in either a lateral or vertical plane. 
Depression was defined as a decreased response to environmental stimuli (Garosi, 2004).  Pyrexia 
was defined as a rectal temperature greater than 39.2 ̊ C in an unstressed dog (Miller, 2011) with 
persistence at 2 or more checks over 24 hours. Neutrophilic pleocytosis, in CSF, was defined as a 
total nucleated cell count (TNCC) > 5 cells/mm3 and total protein >25mg/dl with >50% of the TNCC 
being neutrophils on a cisternal sample (Desnoyers et al., 2008). No cases had lumbar CSF samples 
taken. 
 
Results 
Inclusion criteria were met by 21 cases. The average age at presentation of the cases was 10 months 
(range 5-18 months). Ten were male and 11 female with 8/21 being neutered (3/11 females and 5/10 
males). Twelve different pure-breeds were represented together with a single cross breed. Of the 
pure-breeds 4 were collies, 4 were Jack Russell terriers, 2 were Weimaraners and all other breeds 
(beagle, Labrador retriever, golden retriever, springer spaniel, corgi, Petit Basset Griffon Vendéen, flat 
coated retriever, cocker spaniel, Shih Tzu and poodle) had a single case each. 
 
A CBC was abnormal in 21/21 cases as follows: neutrophilia in 19 cases (mean 20.24X109/L; 
range11.90-38.96; reference interval 3.00-11.50 X109/L); monocytosis in 19 cases (mean 2.67X109/L; 
range 1.55-4.34; reference interval 0.10-1.50 X109/lL; eosinopenia in 9 cases (mean 0.01X109/L; 
range 0.00-0.07; reference interval 0.20-1.40 X109/L); mild non regenerative anaemia in 5 cases 
(mean 31.6%; range 27.7-34.6; reference interval 35.0-55.0%); and lymphocytosis in 3 cases (mean 
4.45X109/L; range 4.08-4.88; reference interval 0.70-3.60 X109/L). Biochemistry was abnormal in 
19/21 as follows: hypoalbuminaemia in 18 cases (mean 26.1 g/l; range 17.4-31.7; reference range 
32.0-38.0 g/L); hyperglobulinaemia in 10 cases (mean 40.0 g/L; range 35.9-53.9; reference interval 
20.0-35.0 g/L); increased alkaline phosphatase in 16 cases (mean 188.5 IU/L; range 112.0-310.0; 
reference interval 0-110 IU/L); hyperphosphataemia in 15 cases (mean 1.52 mmol/L; range 1.33-2.16; 
reference interval 0.75-1.25 mmol/L); increased total calcium in 7 cases (mean 2.73 mmol/L; range 
2.63-2.85; reference interval 2.30-2.60 mmol/L); hypercholesterolaemia in 7 cases (mean 9.2 mmol/L; 
range 7.3-10.7; reference interval 3.5-7.0 mmol/L); hyperkalaemia in 4 cases (mean 4.76 mmol/L; 
range 4.51-5.20; reference interval 3.50-4.50 mmol/L); increased urea in 1 case (7.2 mmol/L; 
reference interval 2.0-7.0 mmol/L); and raised alanine aminotransferase in 1 case (236 IU/L; 
reference interval 20-60 IU/L). No specific triggers of SRMA were identified from the CBC with 
differential or biochemistry samples in any of the 21 cases.  Two cases had an elevated urine protein 
to creatinine ratio (UP:C) of >0.5 on urinalysis (0.59 and 0.85) but none had any organisms identified 
on urine culture. None of the 21 cases had abnormalities on orthogonal inflated radiographs of the 
thorax. Four dogs had abnormalities identified on abdominal ultrasound as follows:  1 had a 
hypoechoic nodule within the spleen (consistent with splenitis on cytology of an aspirate); and 3 had 
enlarged abdominal lymph nodes (consistent with lymphadenitis on cytology of aspirates). No 
organisms were identified on cytology in these cases. One of the dogs with lymphadenitis had an 
exploratory celiotomy at the referring veterinarians prior to admission, whilst another documented 
gastrointestinal signs with vomiting and diarrhoea.  
 
One dog had aspiration of a mass in the neck which was palpable on general physical examination. 
This documented neutrophilic inflammation on cytology but no pathological organisms were identified 
after culture. This case had an abscess diagnosed 3 months prior to presentation, which occurred 
immediately after placement of a microchip, and had been treated with antibiotics.  
 
A number of dogs underwent additional diagnostic tests. These included: Toxoplasma and Neospora 
serology (on blood) or PCR (on blood or CSF) in 17 cases; Rickettsae PCR (on blood) in 2 cases; 
Bartonella PCR (on blood) in 3 cases; Anaplasma PCR (on blood) in 5 cases; Ehrlichia PCR (on 
blood) in 7 cases; Borrelia PCR (on blood) in 11 cases; joint taps in 17 cases; faecal culture in 2 
cases; CSF culture in 5 cases; and blood culture in 1 case. Five out of 17 cases documented a 
neutrophilic inflammation on joint taps but no pathological organisms were identified on cytology. All 
other tests were unremarkable.  
 
Twenty of the 21 SRMA dogs were treated in the immediate period (7 days) prior to referral as follows: 
18 received antibiosis; 14 had NSAIDs as a sole anti-inflammatory medication; 1 had steroids as their 
sole anti-inflammatory medication; and 1 had steroids and NSAIDs.  
 
Discussion 
No infectious or neoplastic triggers were definitively identified in any of the 21 SRMA cases subjected 
to screening diagnostics recommended for IMHA cases. This included screening for bacterial and 
protozoal diseases.  This mirrors previous studies that have failed to identify triggers for SRMA with 
antemortem diagnostic tests (Scott-Moncrieff et al., 1992) or necropsy and bacteriology, virology and 
histopathology (Harcourt, 1978). In contrast an infection or neoplasm was identified as the trigger in 
35 of 181 cases of IMHA with the same screening diagnostics, although it is unclear if these cases 
were pre-treated with antibiosis and anti-inflammatory drugs as in some of the SRMA cases 
presented here (Wienkle et al., 2005). 
 
Screening diagnostics did identify other inflammatory foci in the abdomen of 4 of the 21 SRMA cases. 
Similarly joint taps identified neutrophilic inflammation in 4 out of 17 SRMA cases. Other inflammatory 
foci have previously been found in association with SRMA ante- and post-mortem (Scott-Moncrieff et 
al., 1992; Webb et al., 2002) and these results may reflect part of the systemic inflammatory response 
that is reported in this disease.  Abdominal lymphadenitis may reflect signs of a gastrointestinal or 
other abdominal infectious or neoplastic trigger for SRMA but none was identified in the present 
cases. Faecal culture was not routinely performed and has not been done so by others in any 
significant numbers. A faecal isolate of C. perfringens was identified in a previous study of SRMA but 
this was not considered an antigenic trigger for SRMA (Scott-Moncrieff et al., 1992). This theory is 
supported by evidence that in one study 71% of clinically normal dogs had C. perfringens isolated in 
their faeces (Weese et al., 2001).   
 
Despite negative urine culture results, two of the SRMA cases had a mild increase in UP:C, as has 
been described previously (Scott-Moncrieff et al., 1992). In the absence of active urine sediment or 
culture indicating infection or gross haematuria this could be secondary to glomerular protein loss 
(Meryl and Littman, 2011). This is most likely secondary to the systemic inflammatory nature of SRMA 
as renal inflammatory foci have been identified previously in SRMA cases (Harcourt, 1978). This 
assumption is supported by the fact that the elevated UP:C  subsequently resolved at recheck 
appointments (2 or 4 weeks later) after immunosuppressive steroid therapy and cessation of 
antibiotics.  
 
CBC documented a neutrophilia and monocytosis with or without a lymphocytosis and eosinopenia in 
the SRMA cases. Neutrophilia, monocytosis and eosinopenia have been described previously in 
SRMA cases (Scott-Moncrieff et al., 1992; Cizinauskas et al., 2000) but lymphocytosis has not. In 
IMHA the CBC usually demonstrates a leukocytosis with neutrophilia and left shift without changes to 
the lymphocyte and eosinophil counts (McManus and Craig, 2001). The lymphocytosis in SRMA may 
be related to the age of these animals, a physiological response to adrenaline release or could reflect 
prolonged immune stimulation that has an alternative immune mediated mechanism compared to 
IMHA (Blackwood, 2005). Eosinopenia in the SRMA cases is most likely secondary to a stress 
leukogram but could reflect acute infection (Blackwood, 2005). Biochemistry documented 
hypoalbuminaemia, hyperglobulinaemia, increased ALP activity, hyperphosphataemia, increased total 
calcium, hypercholesterolaemia, hyperkalaemia, increased urea and increased ALT activity in some of  
the SRMA cases. Hypoalbuminaemia, hyperglobulinaemia, increased ALP, increased ALT and 
hypercholesterolaemia have been described previously in SRMA (Scott-Moncrieff et al., 1992; 
Cizinauskas et al. 2000). It is likely that that raised total calcium and hyperphosphataemia is 
secondary to the young age of the SRMA population whilst the raised potassium may be secondary to 
drug therapy (i.e. NSAIDs), diet or increased leukocyte counts (Skelly and Mellanby, 2005). The 
increased urea was presumptively due to dehydration (supported clinically by tacky mucous 
membranes and a skin tent) in the one case where it was present. 
 
It is possible that the case with the cervical abscess could have had a trigger for its SRMA.  The time 
course between diagnosis of the abscess and SRMA and the fact that no infectious organism was 
identified on cytology or culture of the abscess make this less likely. However, this case was treated 
with antimicrobials prior to referral and an infection may have been present initially.  
 
The same issue of treatment with antibiotics prior to performing screening diagnostics may have 
prevented the identification of a bacterial trigger for SRMA in many of the present cases. In one other 
study antibiotics were instigated before trying to find a trigger for SRMA post mortem but blood, urine, 
CSF and faeces were sent for culture, and abdominal and thoracic radiographs were taken before 
antibacterial therapy began (Scott-Moncrieff et al. 1992). Bacteria were identified on culture in some 
of these samples but felt unlikely to be triggers of SRMA for three reasons: on repeated sampling and 
culture no bacteria were identified in the same cases where bacteria were initially cultured; dogs 
responded to immunosuppressive doses of steroids; and no dogs clinically responded to antibiotics 
that the cultured bacteria were sensitive to. Harcourt (1978) stated that antibiotics did not prevent the 
recurrence of disease in the Beagle colony studied, but it is unclear whether dogs had been treated 
with these drugs at the time of the investigations to try and establish a trigger. Given these findings it 
would seem unlikely that a bacterial trigger was evident in these cases but it cannot be excluded from 
the current study.  
 
The main limitations of this paper are the previous treatment of most cases with antibiotics preventing 
identification of infectious agents and the small numbers described. The low numbers make statistical 
analyses difficult and therefore conclusions are not definitively proven. Case numbers could have 
been increased by including cases over the age of 18 months (5 extra cases), those with other 
neurological signs (3 extra cases) (i.e. paresis, ataxia, menace deficits, anisocoria, strabismus) and 
those with a mixed or mononuclear pleocytosis (7 extra cases) as these have previously been 
described with SRMA (Tipold and Jaggy, 1994). However, including these cases  could have resulted 
in the inclusion of other inflammatory meningioencephalitides (Lowrie, M., et al. 2009). Measuring IgA 
in serum and CSF has been recommended to differentiate SRMA from other inflammatory 
meningioencephalitides (Tipold, 1995) but this was not performed on the dogs included in this 
retrospective study. Additionally increased case numbers in this study would have been possible by 
reducing or changing the number of screening tests performed. If all cases that had some of the 
screening tests noted in the inclusion criteria, a further 21 cases could have been reported. Of these 
further 21 cases that had some of the screening tests performed (including some of the additional 
diagnostics for bacterial and protozoal diseases) no triggers for SRMA were identified. A case control 
study would have allowed statistical comparison between groups and allowed identification of the 
number of inflammatory foci that may be present in dogs presenting with other conditions but similar 
clinical signs. Additionally the relationship between vaccination or drug history and SRMA was not 
examined for these cases despite the link to cases of IMHA. Unfortunately the previous exposure to 
drugs was incomplete in the clinical records.  
 
It is concluded that SRMA cases, with a neutrophilic pleocytosis on CSF analysis, that fall into a 
specific clinical picture (i.e. <18 months of age, with pyrexia, neck pain, depression and no other 
neurological signs) are unlikely to have abnormal findings when screened for infectious or neoplastic 
diseases. This may aid clinicians to define the most cost effective approach in such SRMA cases by 
avoiding further screening diagnostic tests (i.e. cystocentesis urine analysis (including culture), 
complete abdominal ultrasound and orthogonal inflated thoracic radiographs) when not indicated by 
other abnormalities on history or clinical examination.   
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